Journal
EBIOMEDICINE
Volume 24, Issue -, Pages 247-256Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.ebiom.2017.09.012
Keywords
CXCL14; TLR9; CpG DNA; Dendritic cells
Funding
- JSPS KAKENHI [JP25860304, JP23390256, JP16H02611]
- Takeda Science Foundation
- Grants-in-Aid for Scientific Research [17J03475, 16H02611, 16H04728] Funding Source: KAKEN
Ask authors/readers for more resources
CXCL14 is a primordial chemokine that plays multiple roles in tumor suppression, autoimmune arthritis, and obesity-associated insulin resistance. However, the underlying molecular mechanisms are unclear. Here, we show that CXCL14 transports various types of CpG oligodeoxynucleotide (ODN) into the endosomes and lysosomes of bone marrow-derived dendritic cells (DCs), thereby activating Toll-like receptor 9 (TLR9). A combination of CpG ODN (ODN2395) plus CXCL14 induced robust production of IL-12 p40 by wild-type, but not Tlr9knockout, DCs. Consistent with this, ODN2395-mediated activation of DCs was significantly attenuated in Cxcl14-knockout mice. CXCL14 bound CpG ODN with high affinity at pH 7.5, but not at pH 6.0, thereby enabling efficient delivery of CpG ODN to TLR9 in the endosome/lysosome. Furthermore, the CXCL14-CpG ODN complex specifically bound to high affinity CXCL14 receptors on DCs. Thus, CXCL14 serves as a specific carrier of CpG DNA to sensitize TLR9-mediated immunosurveillance. (C) 2017 The Authors. Published by Elsevier B. V. This is an open access article under the CC BY-NC-ND license.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available